StonvexLoading…
StonvexCore line items from VRNS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-27 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $180.49M | $173.13M | $623.53M | $450.16M | $288.59M |
Operating Income | Not available | $-44.48M | $-146.51M | $-116.25M | $-80.32M |
Net Income | Not available | $-36.85M | $-129.32M | $-101.55M | $-35.82M |
EPS (Diluted) | $0.01 | $-0.32 | $-1.13 | $-0.90 | $-0.64 |
Total Assets | Not available | $1.63B | $1.79B | $1.67B | $1.62B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $179.34M | $202.48M | $157.35M | $199.23M |
Free Cash Flow OCF − CapEx | Not available | $50.07M | $134.80M | $114.06M | $83.63M |
Shares Outstanding | Not available | 114.81M | 117.55M | 117.90M | 112.05M |